Title : The Efficacy of Combined Cisplatin and Nanoparticle Albumin-Bound Paclitaxel in a Stage IV Pancreatic Squamous Cell Carcinoma Patient With a Somatic BRCA2 Mutation: A Case Report.

Pub. Date : 2021

PMID : 33996534






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Our case demonstrated a favorable clinical activity and survival advantage of the combined cisplatin and nanoparticle albumin-bound paclitaxel, which might serve as a therapeutic option for the patient with BRCA-mutant pancreatic SCC. Cisplatin BRCA1 DNA repair associated Homo sapiens